Pediatric Hematology-Oncology Fellowships in Asia: 60 Recorded Programs

Designed for advanced trainees in paediatric haematology-oncology. Candidates must hold qualifications registrable with the Singapore Medical Council and have the support of a host institution in their home country.

POEM CCI grant selection and AUBMC Observer Visiting Resident electives are separate approval routes. POEM lists pediatric hematology-oncology/BMT, while AUBMC publishes general physician observer rules; applicability of the GME route to a POEM placement requires CCI/GME confirmation. Nursing/pharmacy and hands-on routes are excluded from these physician-observer statements.

For the separately published AUBMC Observer Visiting Resident route: currently enrolled in residency/fellowship and home programme director approval; final host approval and space availability required.

A national FCPS pediatric subspecialty training/examination framework with core and advanced components and a route for prior specialists. It is not a named hospital placement, a current vacancy or uniformly a five-year post-specialty fellowship.

The October 2022 framework lists a five-year specialized-subject pathway, including core and advanced training. Qualified FCPS/MD/MS holders have a separately described advanced-training route; five years is not uniformly the additional post-specialty period.

The 2022 framework requires MBBS/BDS and full BMDC registration for Part-I, with the pediatric subspecialties taking Part-I in Paediatrics. Final-exam eligibility includes Part-I, midterm and advanced training, or the separately specified route for relevant FCPS/MD/MS holders.

The2024 Punjab second-fellowship policy describes two to three years depending on the degree-awarding institution, with initial one-year appointment and performance-dependent annual extension. An exact duration for this hospital’s FCPS discipline is not established.

The17May2024 Punjab second-fellowship policy lists FCPS Paediatrics as the prior specialty for this paediatric second-fellowship discipline. Its general pre-qualifications require a PM&DC-recognised LevelIII qualification and age below50 at the submission deadline. These are dated provincial policy terms, not a confirmed current intake.

Under the2024 Punjab policy, eligible postgraduate trainees receive the government-prescribed stipend; in-service deputationists receive admissible pay/allowances under applicable rules. Support is limited to the degree-awarding institution’s required two/three-year training period. No current amount or individual award is established.

The published standard hands-on fee table lists no fee for Malaysian public-institution candidates, RM10,000 per six months for Malaysian private-institution candidates and RM12,000 per six months for non-Malaysians. This is tuition/attachment cost, not a stipend; these paediatric courses are not named in the premium-course list.

UMMC’s general policy requires a recognized master’s/clinical-master’s qualification or equivalent, clinical-department head support and Credentialing and Privileging Committee approval. Department-specific module requirements also apply.

The general schedule lists RM18,000/year for Malaysian and RM36,000/year for non-Malaysian clinical fellowship/subspecialty trainees, plus RM100 management fees. Government-agency/university-teaching-hospital applications are stated to incur management fees only; listed income-country discounts may apply. This is a fee policy, not a salary offer.

The university-wide basic entry criterion is completion of a full residency in the parent specialty. The page says most fellowship programs require FCPS in that parent specialty; the specific program’s complete selection criteria are separate.

The fellow salary page lists monthly amounts of Rs 165,000 (Fellow I), Rs 176,000 (Fellow II) and Rs 187,000 (Fellow III). The page does not state an effective year or the applicant’s appointment level.

LPDP-listed domestic pediatric hematology and oncology competency fellowship placement. The scheme adds specified competencies within a subspecialty and is distinct from a full subspecialist qualification. Host curriculum, case exposure and current capacity require separate sources.

The source table identifies Pediatrics specialist (Sp.A) entry. For the January 2026 LPDP funding route, applicants must be Indonesian specialist physicians with host acceptance and referring-hospital endorsement; this does not establish all host admission routes.

The January 2026 LPDP scheme covers approved fellowship tuition, book allowance, monthly living support, insurance and eligible travel/other support. These are scholarship components, not a hospital salary or guaranteed individual award.

LPDP-listed domestic pediatric hematology and oncology competency fellowship placement. The scheme adds specified competencies within a subspecialty and is distinct from a full subspecialist qualification. Host curriculum, case exposure and current capacity require separate sources.

The source table identifies Pediatrics specialist (Sp.A) entry. For the January 2026 LPDP funding route, applicants must be Indonesian specialist physicians with host acceptance and referring-hospital endorsement; this does not establish all host admission routes.

The January 2026 LPDP scheme covers approved fellowship tuition, book allowance, monthly living support, insurance and eligible travel/other support. These are scholarship components, not a hospital salary or guaranteed individual award.

LPDP-listed domestic pediatric hematology and oncology competency fellowship placement. The scheme adds specified competencies within a subspecialty and is distinct from a full subspecialist qualification. Host curriculum, case exposure and current capacity require separate sources.

The source table identifies Pediatrics specialist (Sp.A) entry. For the January 2026 LPDP funding route, applicants must be Indonesian specialist physicians with host acceptance and referring-hospital endorsement; this does not establish all host admission routes.

The January 2026 LPDP scheme covers approved fellowship tuition, book allowance, monthly living support, insurance and eligible travel/other support. These are scholarship components, not a hospital salary or guaranteed individual award.

LPDP-listed domestic pediatric hematology and oncology competency fellowship placement. The scheme adds specified competencies within a subspecialty and is distinct from a full subspecialist qualification. Host curriculum, case exposure and current capacity require separate sources.

The source table identifies Pediatrics specialist (Sp.A) entry. For the January 2026 LPDP funding route, applicants must be Indonesian specialist physicians with host acceptance and referring-hospital endorsement; this does not establish all host admission routes.

The January 2026 LPDP scheme covers approved fellowship tuition, book allowance, monthly living support, insurance and eligible travel/other support. These are scholarship components, not a hospital salary or guaranteed individual award.

LPDP-listed domestic pediatric hematology and oncology competency fellowship placement. The scheme adds specified competencies within a subspecialty and is distinct from a full subspecialist qualification. Host curriculum, case exposure and current capacity require separate sources.

The source table identifies Pediatrics specialist (Sp.A) entry. For the January 2026 LPDP funding route, applicants must be Indonesian specialist physicians with host acceptance and referring-hospital endorsement; this does not establish all host admission routes.

The January 2026 LPDP scheme covers approved fellowship tuition, book allowance, monthly living support, insurance and eligible travel/other support. These are scholarship components, not a hospital salary or guaranteed individual award.

LPDP-listed domestic pediatric hematology and oncology competency fellowship placement. The scheme adds specified competencies within a subspecialty and is distinct from a full subspecialist qualification. Host curriculum, case exposure and current capacity require separate sources.

The source table identifies Pediatrics specialist (Sp.A) entry. For the January 2026 LPDP funding route, applicants must be Indonesian specialist physicians with host acceptance and referring-hospital endorsement; this does not establish all host admission routes.

The January 2026 LPDP scheme covers approved fellowship tuition, book allowance, monthly living support, insurance and eligible travel/other support. These are scholarship components, not a hospital salary or guaranteed individual award.

LPDP-listed domestic pediatric hematology and oncology competency fellowship placement. The scheme adds specified competencies within a subspecialty and is distinct from a full subspecialist qualification. Host curriculum, case exposure and current capacity require separate sources.

The source table identifies Pediatrics specialist (Sp.A) entry. For the January 2026 LPDP funding route, applicants must be Indonesian specialist physicians with host acceptance and referring-hospital endorsement; this does not establish all host admission routes.

The January 2026 LPDP scheme covers approved fellowship tuition, book allowance, monthly living support, insurance and eligible travel/other support. These are scholarship components, not a hospital salary or guaranteed individual award.

LPDP-listed domestic pediatric hematology and oncology competency fellowship placement. The scheme adds specified competencies within a subspecialty and is distinct from a full subspecialist qualification. Host curriculum, case exposure and current capacity require separate sources.

The source table identifies Pediatrics specialist (Sp.A) entry. For the January 2026 LPDP funding route, applicants must be Indonesian specialist physicians with host acceptance and referring-hospital endorsement; this does not establish all host admission routes.

The January 2026 LPDP scheme covers approved fellowship tuition, book allowance, monthly living support, insurance and eligible travel/other support. These are scholarship components, not a hospital salary or guaranteed individual award.

LPDP-listed domestic pediatric hematology and oncology competency fellowship placement. The scheme adds specified competencies within a subspecialty and is distinct from a full subspecialist qualification. Host curriculum, case exposure and current capacity require separate sources.

The source table identifies Pediatrics specialist (Sp.A) entry. For the January 2026 LPDP funding route, applicants must be Indonesian specialist physicians with host acceptance and referring-hospital endorsement; this does not establish all host admission routes.

The January 2026 LPDP scheme covers approved fellowship tuition, book allowance, monthly living support, insurance and eligible travel/other support. These are scholarship components, not a hospital salary or guaranteed individual award.

LPDP-listed domestic pediatric hematology and oncology competency fellowship placement. The scheme adds specified competencies within a subspecialty and is distinct from a full subspecialist qualification. Host curriculum, case exposure and current capacity require separate sources.

The source table identifies Pediatrics specialist (Sp.A) entry. For the January 2026 LPDP funding route, applicants must be Indonesian specialist physicians with host acceptance and referring-hospital endorsement; this does not establish all host admission routes.

The January 2026 LPDP scheme covers approved fellowship tuition, book allowance, monthly living support, insurance and eligible travel/other support. These are scholarship components, not a hospital salary or guaranteed individual award.

LPDP-listed domestic pediatric hematology and oncology competency fellowship placement. The scheme adds specified competencies within a subspecialty and is distinct from a full subspecialist qualification. Host curriculum, case exposure and current capacity require separate sources.

The source table identifies Pediatrics specialist (Sp.A) entry. For the January 2026 LPDP funding route, applicants must be Indonesian specialist physicians with host acceptance and referring-hospital endorsement; this does not establish all host admission routes.

The January 2026 LPDP scheme covers approved fellowship tuition, book allowance, monthly living support, insurance and eligible travel/other support. These are scholarship components, not a hospital salary or guaranteed individual award.

LPDP-listed domestic pediatric hematology and oncology competency fellowship placement. The scheme adds specified competencies within a subspecialty and is distinct from a full subspecialist qualification. Host curriculum, case exposure and current capacity require separate sources.

The source table identifies Pediatrics specialist (Sp.A) entry. For the January 2026 LPDP funding route, applicants must be Indonesian specialist physicians with host acceptance and referring-hospital endorsement; this does not establish all host admission routes.

The January 2026 LPDP scheme covers approved fellowship tuition, book allowance, monthly living support, insurance and eligible travel/other support. These are scholarship components, not a hospital salary or guaranteed individual award.

A named pediatric advanced-training programme with a separate faculty-wide international application policy. Faculty fees and document rules do not independently confirm a current programme opening or the applicant’s clinical privileges.

The faculty lists tuition of approximately THB 350,000 or more per academic year and a non-refundable THB 4,500 first-arrival processing fee. Its FAQ says no institute scholarship or monthly stipend is provided and labels the application fee free; these charges are distinct.

The 2021 NBEMS annual-review inventory explicitly lists Paediatric Hemato-Oncology under FELLOWSHIP at named institutions. This directory record describes the national FNB pathway rather than a single host’s currently advertised intake.

ICP seat matrix (July 2026 session), centre C-02-5: course/centre fee 240000; chapter fee 25,000; stipend listed as available; accommodation listed as available. Amounts are as printed; the currency and the stipend value are not stated.

ICP seat matrix (July 2026 session), centre C-02-1: course/centre fee 75000; chapter fee 25,000; stipend listed as available; accommodation not listed. Amounts are as printed; the currency and the stipend value are not stated.

ICP seat matrix (July 2026 session), centre C-02-4: course/centre fee 50000; chapter fee 25,000; stipend listed as available; accommodation not listed. Amounts are as printed; the currency and the stipend value are not stated.

ICP seat matrix (July 2026 session), centre C-02-2: course/centre fee 100000; chapter fee 25,000; stipend listed as available; accommodation listed as available. Amounts are as printed; the currency and the stipend value are not stated.

ICP seat matrix (July 2026 session), centre C-02-6: course/centre fee 25000; chapter fee 25,000; stipend listed as available; accommodation not listed. Amounts are as printed; the currency and the stipend value are not stated.

The prospectus explicitly permits applicants with FCPS/MD Paediatrics to enter Phase B in Paediatric Gastroenterology, Haematology-Oncology or Nephrology, subject to the stated admission process; this differs from entry into the full integrated residency.

Foreign-applicant framework: approved MBBS/equivalent, two years since graduation including one-year internship, and maximum age 45 at enrolment. Specific eligibility for direct advanced Phase B entry remains course-dependent.

Institutional clinical fellowship ending with a letter of satisfactory completion. The separate CBCC recruitment calendar distinguishes closed July 2027 recruitment from a future July 2028 application period.

SMC temporary-training registration criteria and normally at least 36 months of pediatric experience after internship; less experience may be considered individually. Prior hematology/oncology experience is preferred.

Tailored for fellows-in-training from the ASEAN region, preferably with experience in the field. Candidates must hold qualifications registrable with the Singapore Medical Council and have the support of a host institution in their home country.

LPDP-listed domestic pediatric hematology and oncology competency fellowship placement. The scheme adds specified competencies within a subspecialty and is distinct from a full subspecialist qualification. Host curriculum, case exposure and current capacity require separate sources.

The source table identifies Pediatrics specialist (Sp.A) entry. For the January 2026 LPDP funding route, applicants must be Indonesian specialist physicians with host acceptance and referring-hospital endorsement; this does not establish all host admission routes.

The January 2026 LPDP scheme covers approved fellowship tuition, book allowance, monthly living support, insurance and eligible travel/other support. These are scholarship components, not a hospital salary or guaranteed individual award.

NU SOM’s page states that doctors who completed a General Pediatrics residency (at NU SOM or another residency accredited by the Ministry of Health of Kazakhstan) can apply for any of the listed pediatric subspecialties; doctors from other recognised adult or children’s specialty residencies can apply only for the subspecialty consistent with their residency training (for example, neurology residents to pediatric neurology).

Sidra Medicine’s page lists these entry requirements: Completion of an ACGME-I accredited or equivalent residency training program in Pediatrics. Board certification in core specialty (Pediatrics). Hold a valid Medical License or be eligible for licensure in Qatar .

For 2026/2027, specialist-training GPA at least 3.00, an Sp.A college competency certificate, and at least one continuous year working in a subspecialty at an IPDSA or three years outside an IPDSA, with employer evidence. The page also requests relevant prior symposium/workshop/training participation.

Entry requires a medical degree and a paediatric specialist qualification (specialist transcript GPA of at least 3.00 on a 4-point scale, from a programme accredited A or B), at least 1 year of clinical experience at a paediatric specialist education institution, or 2 years at one of its network hospitals, or 3 years at another hospital, with recommendations from the sending hospital, the regional IDAI branch head and the IDAI coordinating-unit head for the interest area, and a work agreement with the sending hospital. Track-specific: Haematology-Oncology: recommendations from 2 consultants in the interest area in UGM’s paediatrics department.

Program page states: “Program Requirements The Pediatrics Hematology Oncology Fellowship candidates must be graduates of an accredited medical school, have completed an accredited paediatrics residency, and be Jordanian/Arab board certified or eligible.”

The official department page lists this subspecialty program and its training description, but also contains 2017 research examples and an August 2018 staff roster. No current intake, program director or complete admission specification is confirmed from this page.

By appointment, completed or expected to complete pediatric specialist training, with pediatric specialist certification already obtained or expected within the appointment year. The page excludes applicants already holding pediatric hematology/oncology, hematology or certified cancer-treatment credentials.

NU SOM’s page states that doctors who completed a General Pediatrics residency (at NU SOM or another residency accredited by the Ministry of Health of Kazakhstan) can apply for any of the listed pediatric subspecialties; doctors from other recognised adult or children’s specialty residencies can apply only for the subspecialty consistent with their residency training (for example, neurology residents to pediatric neurology).

CPSP lists this pediatric pathway under Second Fellowship. This national specialty listing is not a named hospital placement or a dated open recruitment; the page’s generic four-to-five-year FCPS statement does not establish this second fellowship’s duration.